Studies have shown that antipsychotics can elevate risks associated with pregnancy and neonatal prognosis, including preterm delivery, low or high neonatal weight, gestational diabetes, neonatal withdrawal reactions, and abnormal muscle movements. Discontinuation of all antipsychotic medications prior to pregnancy is recommended, and if antipsychotic use is unavoidable, it should be used appropriately according to the principles of evidence-based medicine to minimize the risk of pregnancy. I. FDA Classification of Antipsychotic Drugs and Pregnancy Safety: A. No adverse effects were found in controlled studies. An antipsychotic drug has not been found to be free of any adverse effects on pregnancy. B. There is no evidence of adverse reactions in humans. Such drugs include: clozapine, buspirone, bupropion, maprotiline, zolpidem. C. The presence of adverse reactions cannot be excluded. These drugs include: olanzapine, paliperidone, risperidone, quetiapine, ziprasidone, aripiprazole, chlorpromazine, fenadine, haloperidol, fluoxetine, sertraline, escitalopram, citalopram, fluvoxamine, duloxetine, venlafaxine, mirtazapine, doxepin, trazodone, donepezil, gabapentin. D. There has been evidence of adverse reactions. Such drugs include: sodium valproate, lithium, carbamazepine, diazepam, alprazolam, lorazepam, midazolam, clonazepam, paroxetine, amitriptyline, mipramine, promethazine. X. Prohibited during pregnancy. Such drugs include: eszopiclone, triazolam. In addition, sulpiride, amisulpride and the risk of pregnancy are not known. If pregnancy is required, the most appropriate form of antipsychotic medication should be considered prior to conception. 2. Use the drug with the least possible effect on the fetus. 3, as far as possible to play the role of non-pharmacological treatment, such as psychotherapy. 4. Patients should pay close attention to the advice provided by psychiatrists, psychologists and obstetricians and gynecologists and follow up regularly with these departments. Fetal development and the mother’s mental status should be adequately monitored during the course of pregnancy. 5. Obtain at baseline those biological indicators that may be affected by the condition and medications. 6. Identify early warning signs of psychiatric relapse and the medical pathway after relapse. 7. Whether or not to breastfeed should be adequately discussed with the psychiatrist to try to avoid the adverse effects of antipsychotic drugs on breastfeeding.